INTRODUCTION
During postnatal life, the bone marrow (BM) supports both the self renewal and differentiation of hematopoietic stem cells (HSCs) in specialized niches (1) (2) . HSCs are kept in a low proliferative, relatively quiescent state in close proximity to stromal cells and osteoblasts, forming these specialized niches (3) (4) (5) . The interaction of HSCs with their niches, especially the bone, is crucial to prevent exhaustion of HSCs from uncontrolled cell-cycle entry and excessive proliferation (6) (7) (8) . In addition, the niche and its components protect the HSCs from stress such as accumulation of reactive oxygen species and DNA damage (3) .
Endocannabinoids constitute a novel family of lipid ligands that act via specific G-protein-coupled receptors CB 1 and CB 2 (9) (10) (11) (12) (13) (14) . The endocannabinoid system includes the receptors (CB 1 and CB 2 ), their endogenous ligands (endocannabinoids), anandamide (AEA) and 2-arachydonoyl-glycerol (2-AG), exogenous cannabinoid ligands and hydrolyzing enzymes [Fatty acid amide hydrolase (FAAH) and MGL]. Endocannabinoids were shown to be synthesized in vivo from phospholipids (15) . The effects of endocannabinoids at the CB 1 receptors are terminated by their rapid uptake through a high affinity membrane transporter and subsequent intracellular degradation by FAAH (16) . The CB 1 receptor is highly expressed in the CNS, with particularly high levels in the neocortex, hippocampus, basal ganglia, cerebellum and brainstem (16) (17) (18) (19) . Endocannabinoid modulate neurotransmitter release and thus exert a wide array of actions including motor function, cognitive processes, emotion, sensory perception, endocrine functions and food intake (9) . Furthermore, cannabinoid signaling via CB 1 receptor modulates a range of physiological functions in the adult body (19) .
The CB 2 receptor displays a more selective pattern of expression mainly in immune cells, such as B and T lymphocytes (20) . In regard to hematopoietic system, several studies have addressed the expression and function of cannabinoid receptors in mature hematopoietic and immune cells (21-23), while the effect of cannabinoids on HSPCs has not been investigated in depth. Noteworthy, the endocannabinoids promoted the growth of primary murine marrow progenitor cells (24). We also recently reported the role of cannabinoid receptors in survival of murine embryonic stem cells and their hematopoietic differentiation (25).
Here, we studied the expression of endocannabinoids in the stromal BM niches under homeostasis conditions and inflammatory response following exposure to the endotoxin LPS as well as the expression of cannabinoid receptors in HSPCs. We report the expression of endocannabinoids in stromal BM niches and their increased secretion following exposure to LPS, resulting in migration and trafficking of HSPCs from the BM niches to the peripheral blood. 9 -tetrahydrocannabinol (THC), or ACEA (all ligands at a dose of 10 mg/kg) either alone or in the presence of cannabinoid receptor antagonists AM251 (for CB 1 ) (5 mg/kg), and/or AM630 (for CB 2 ) (5 mg/kg), as indicated. URB597 (0.5 mg/kg) was injected i.p. one hour prior to the last G-CSF injection. Twenty-four hours following the last injection of cannabinoid agonists and URB597, mice were sacrificed; dissected and peripheral blood was collected by cardiac puncture. Control mice received i.p. injections of vehicle alone daily for 4 days, and twenty-four hours following the last injection, mice were sacrificed, dissected and peripheral blood was collected (0.6 ml from each mice) by cardiac puncture. White blood cells (WBC) were isolated by Ficoll separation. Briefly, blood was diluted to 6 ml and was overlaid on the 5 ml Ficoll layer. Tubes were centrifuged at 2000 rpm at 18C for 30 min. The top layer was removed slowly with a Pasteur pipette and the WBC layer was transferred into 8-9 ml DPBS + (DPBS + containing 2% FBS) in a 15 ml conical tube. Tubes were spun at 1500 rpm at 4C for 5 to 7 min and then the pellet was resuspended in DPBS + . The cells were collected and used for the colony-formation assays using MethoCult media, according to the protocol of StemCell Technologies (Tukwila, WA). The MethoCult medium containing 110 5 cells/ml was added into 35 mm Petri dishes and incubated at 37C in a 5% CO 2 incubator for 10-14 days. Triplicate assays were performed for each sample. Following the incubation period, the numbers of colonies were determined by light microscopy. Positive colonies were scored on the basis of an accumulation of 40 or more cells.
EXPERIMENTAL PROCEDURES

Antibodies, chemical and biological compounds-Rabbit
HSPC assays
The murine cells were assessed using MethoCult 03434 (Stem Cell Technologies Inc.). Human cells were assayed for CFU-GM, BFU-E, and CFU-GEMM using ingredients and cytokine combinations as noted elsewhere (30 RT-PCR analysis of CB 1 and CB 2 expression -RNA from total bone marrow MNCs or as indicated was extracted using the RNeasy Mini Kit along with DNA Shredder Kit (both from Qiagen, Valencia, CA) following the manufacturer's protocol. A QIAshredder spin column and DNase I digestion were included in the isolation procedure to limit the possibility of PCR amplification of CB 1 and CB 2 from genomic DNA. cDNA and PCR amplification were performed with the BD Biosciences TITANIUM One-Step RT-PCR Kit using 200 ng of RNA as a template for first-strand synthesis. CB 1 was amplified using primers: 5'-CGT GGG CAG CCT GTT CCT CA-3' and 5'-CAT GCG GGC TTG GTC TGG-3', which yield a product of 403 bp. CB 2 was amplified using: 5'-CCA TGG AGG AAT GCT GGG TG-3' and 5'-TCA GCA ATC AGA GAG GTC TAG-3' , which yield a product of 1100 bp. GAPDH was used as a positive control with primers: 5'-CTC ACT GGC ATG GCC TTC CG-3' and 5'-ACC ACC CTG TTG CTG TAG CC-3', which yield a product of 292 bp. The template was first denatured at 94C for 2 min followed by 35 cycles (94C for 30 sec, 58C for 30 sec and 68C for 1 min), followed by 68C for 2 min in a myCycler Personal Thermal Cycler (Bio-Rad Laboratories, Inc). Aliquots (20 µl) of the PCR products were run on a 1.5% agarose gel containing 0.5 µg/ml ethidium bromide.
Endocannabinoid Levels in Bone Marrow
Stromal Cells: 10 7 cells of murine bone marrow cells were analyzed for endocannabinoid expression levels. Mixtures of the 2-AG and AEA and their denatured analogs that had been stored at -80°c were further diluted in a 20mg/ml solution of fatty acid free bovine serum albumin (BSA) to stimulate analyte-free plasma and in ethanol to make the calibration standards, quality control (QC) samples and reference samples, as previously described (25,31). The calibration curves were constructed from the ratios of the peak areas of the analytes versus the IS. mice were used to prepare protein lysates for Western blot analysis, using specific antibodies for CB 1 and CB 2 . Actin antibody was used as internal control for loading.
LC-MS Analysis for endocannabinoids -
Statistical analysis -The statistical significance of the results reported hereby was determined by a two-tailed t test.
P<0.01 and P<0.05 were considered significant, as indicated.
RESULTS
Expression
of endocannabinoids in BM-stromal cells -In order to study the role of endocannabinoids in hematopoietic stem cell niche, we examined the expression of 2-AG and AEA in bone marrow stromal cells. As shown in Table 1 , both 2-AG and AEA were detected in stromal cells, with AEA at 35.2pg/10 7 cells and 2-AG at 75.2ng/10 7 cells. Of note, the level of 2-AG synthesis were much greater (approx.1000 fold, ng) compared to AEA (pg). However, under stress induced inflammatory responses following administration of the endotoxin LPS, enhanced expression of 2-AG and AEA (Table 1) were observed, resulting in migration and trafficking of HSPCs from the bone marrow niches to the blood circulation (Fig. 1) . This mobilization was impaired in
Cnr1
-/-and Cnr2 -/-mice (Fig.1A) . Further, there was a synergistic effect of LPS, when co-administered with the FAAH inhibitor URB597, (which results in increased AEA levels), in mobilization of HSPCs (Fig. 1B) . These results suggest that endocannabinoids induce migration and trafficking of HSPCs, and that this migration is enhanced under stress conditions. Expression of CB 1 cannabinoid receptors in murine bone marrow cells -Next, we evaluated the expression of CB 1 receptors on murine bone marrow mononuclear cells. A total of 27.4% mononuclear cells expressed the CB 1 receptor (Fig. 2A) . We also assessed the expression of the CB1 receptors in Side Population (SP) as well as LSK (Lin stem/progenitor cell populations obtained from mouse bone marrow. We observed that 17.6% of the SP cells expressed CB 1 on their surface ( Fig. 2A) , and the LSK cells derived from bone marrow also expressed CB 1 ( Figure 2B ). mice were used on a background of C57BL/6J mice and were genotyped and characterized in our group (Fig. 3) . The control mice were C57BL/6J mice. Cnr1
Analyses of Cnr1
-/-mice lack the expression of CB 1 protein (Fig. 3B) and, Cnr2 -/-mice lack the expression of CB 2 protein (Fig. 3D) (Fig. 3I) .
Further, bone marrow cells derived from mice harboring knockout of the FAAH enzyme (FAAH-/-), and thus accumulating anandamide in sites of its natural production, produced more progenitor colonies in the CFU assay (Fig. 3J) , suggesting a stimulatory role of AEA towards hematopoiesis.
Effects of cannabinoid ligands on colony formation and migration of human and murine HSPCs in vitro -
To study the direct actions of cannabinoids on HSPCs, we first assessed the effects of cannabinoid agonist CP55940 on colony formation by human CD34 + and murine bone marrow-derived cells in vitro. CD34+ cells with the cannabinoid agonist CP55940, yielded a significant increase in colony numbers as compared to control non-stimulated cells (Fig. 4A) . Similarly, treatment of WT murine bone marrow cells with CP55940 yielded an increase in colony number (Fig.  4B) . The effect of cannabinoid ligands on the chemotaxis of human CD34 + cells and murine LSK cells was then analyzed. CP55940 induced a significant increase in the migration of human CD34 + cells (Fig.  4C ) and murine LSK cells (Fig. 4D) . Further, cannabinoid-induced migration of bone marrow cells from Cnr1 -/-knockout mice was severely impaired, as compared to WT mice (Fig. 4E ). These results demonstrate that cannabinoid ligands and cannabinoid receptors are involved in HSPC chemotaxis and migration.
Effects of the CB 1 cannabinoids on HSPC mobilization in vivo -To examine the effects of exogenous cannabinoids on the mobilization of HSPC in vivo, we employed a mouse model of HSPC mobilization from the bone marrow to the circulation, in which the number of circulating HSPC in blood is assessed by the number of colonies formed in semi-solid medium. Treatment of WT mice with either ACEA (CB 1 specific), or CP55940 resulted in a significant (P<0.01) increase in the number of hematopoietic colonies in peripheral blood (Fig. 5A ). In addition, THC induced mobilization of HSPCs (Fig. 5B) , which was inhibited by the cannabinoid receptor antagonists AM251 (selective for CB 1 ) indicating the involvement of CB 1 receptors in mobilization (Fig. 5C) (Fig. 6B) . To evaluate the effects of increased endocannabinoid levels on HSPC-mobilization, we used the FAAH inhibitor, URB597 which inhibits AEA degradation, resulting in accumulation of AEA. Treatment of mice with URB597 significantly increased the incidence of HSPCs in the peripheral blood (Fig. 6C) . In addition, combined treatment of G-CSF and URB597 had a synergistic effect in HSPC-mobilization, confirming the capability of endocannabinoids to modulate G-CSF-induced HSPC -mobilization (Fig.  6C ).
DISCUSSION
In this study, we examined the role of the endocannabinoid system in hematopoiesis. We observed that the BM niches express and secrete endocannabinoids (AEA and 2-AG) and this secretion is significantly elevated in the presence of a stress inducer such as LPS (Table 1 ). In addition, these endocannabinoids can bind and activate CB1 receptors expressed on murine HSPCs (Fig. 2) . Endocannabinoids induced by LPS as well as administration of exogenous cannabinoid agonists such CP55940, induced chemotaxis migration and mobilization of HSPCs from the BM niches to the blood circulation (Fig.4) . Further, G-CSF-induced HSPC mobilization was mediated by endocannabinoids and was impaired in Cnr1 -/-mice (Fig. 6 ).
Cnr1 -/-and
Cnr2
-/-mice also presented a decrease in SP-side population of HSPCs, while FAAH-/-mice, which have significant elevated levels of AEA, had an increased CFU colony formation (Fig. 3) . Thus, these data collectively show that the endocannabinoid system is involved in hematopoiesis and plays a role in the interaction of HSPCs with their BM niches.
Lipopolysaccharide (LPS), a cell wall component of Gram-negative bacteria, causes a marked increase in the circulating cytokines (eg. IL-1β, IL-6 and TNF-α) acting as a cytokine inducer. LPS administration in vivo induces inflammatory response and alters metabolism. This makes the use of LPS injection a valuable model in the study of the mechanisms of the inflammatory response, which is mediated via the action of proinflammatory cytokines, affecting the homing of the stem cells to sites of inflammatory areas (38). LPS was shown to inhibit neural stem cell proliferation (39) and to induce migration of bone marrow cells in mice (40). LPS was also shown to stimulate calcium signaling via G-protein coupled receptor-mediated phospholipases C activation and generation of phosphatidylsereine-specific phospholipases A2 activation (41). Therefore, we examined the effects of LPS on cellular activities that include increase in endocannabinoid levels and modulation of hematopoietic stem and progenitor cell migration.
Understanding of the signals that regulate HSCs development and the intrinsic and extrinsic mechanisms that are involved in maintenance of HSC in the bone marrow niches are crucial for proper hematopoiesis. Hematopoiesis is a life long process in which HSPCs differentiate into mature blood cells. These HSCs are valuable in a clinical setting for patients requiring hematopoietic repair (31-37). The current treatment involves hematopoietic stem cell transplantation with HSPCs obtained from mobilized peripheral blood or umbilical cord blood (31). Repopulation of hematopoiesis is a multistep process that is regulated by the ability of HSPCs to migrate, home to the appropriate marrow niches and differentiate to mature blood cells. Hence, insights into the physiological stimuli as well as external signals that induce HSPC exist from the bone marrow and traffic to peripheral blood is important for proper hematopoiesis repair. Here, we provide new evidence on the involvement of the endocannabinoid system in hematopoiesis by inducing migration and mobilization of HSPCs from the BM niches to the blood circulation following exposure to stress inducer such as LPS, or to exogenous cannabinoid agonists. The migration of HSPCs to the peripheral circulation may limit tissue damage and contribute to hematopoietic repair. Endocannabinoids may regulate hematopoiesis in the BM by maintaining important HSPC functions such as survival.
Endocannabinoids have been reported as positive or negative factors in hematopoietic cell migration and differentiation (24). Endocannabinoids were shown to directly modulate hematopoietic cell migration and differentiation as noted by increased of CFU-GEMM (24). Further, endocannabinoids play important role in endotoxic shock and inflammation (9) . LPS was shown to stimulate the production of AEA in human lymphocytes, macrophages and 2-AG in rat platelets (9) . LPS may induce the expression of additional endocannabinoids in the BM, in addition to 2-AG and AEA, the main two endocannabinoids express in vivo. The level of AEA in brain was reported to be 35 ± 8 pmol/g and 2-AG levels were in brain was reported to be 62 ± 1.8 nmol/g as compared to the expression in blood of AEA (2.5 ± 0.7 pmol/g) and 2-AG (10 -3 nmol/g) (42). Here, we report that 2-AG and AEA are found in similar levels to those reported in brain. The presence of endogenous cannabinoids in immune cells, hematopoietic cells and BM niches suggest that they play a critical physiological role, the precise nature of which remains to be characterized. Increased elevated levels of AEA and 2-AG may further protect HSPCs from endotoxic shock and apoptosis and induce their migration from the BM niches to the blood circulation following insult.
These studies also have important implication of the endocannabinoid system in HSPC homing and engraftment of HSPCs in the bone marrow. Although a very large number of HSPCs are used in the clinical procedure, the homing efficiency of HSPCs following stem cell transplantation is low. G-CSF was found to govern specific aspects of HSC localization and engraftment to the BM (43). In addition, prostaglandin E2-prostaglandin receptors and adrenergic receptors were also reported to enhance stem cell transplantation in mice (44). Here, we show that endocannabinoids, as components of the endocannabinoid system are also important in stem cell mobilization. Thus, identification of additional physiological systems that can increase homing efficiency and/or increase the nurturing capacity of the niche or increase the number of cells that can be mobilized for in vivo transplantation is crucial for HSPCs and HSCs based therapies. Based on this study, we prepare that Pharmacological intervention targeted towards the endocannabinoid system can be a novel modality for HSPCs-based therapies in patients. 
FIGURE LEGENDS FIGURE 1 (A) Induction of HSPC mobilization in wild-type (WT) versus Cnr1
-/-mice. LPS was injected i.p. at a dose of 2µg/kg. Mice were sacrificed five days after injection of LPS and the incidence of PB-HPC was evaluated using colony-formation assay as described in the Methods section. These are representative experiments out of duplicate experiments involving 3 mice per treatment group. *P<0.01 versus control; **P<0.05 versus LPS alone. (B) Effects of pre-treatment with URB597 on LPS-induced mobilization of HSPC. Balb/c mice were injected i.p. with URB597 one hour prior to i.p. inoculation of LPS (2µg/kg). Mice were sacrificed five days after injection of LPS and the incidence of PB-HSPC was evaluated using colony-formation assay.*P<0.05 as compared to vehicle control; **p<0.05 as compared to LPS alone 
